Differences in nitric oxide steady states between arginine, hypoxanthine, uracil auxotrophs (AHU) and non-AHU strains of Neisseria gonorrhoeae during anaerobic respiration in the presence of nitrite.
Neisseria gonorrhoeae can grow by anaerobic respiration using nitrite as an alternative electron acceptor. Under these growth conditions, N. gonorrhoeae produces and degrades nitric oxide (NO), an important host defense molecule. Laboratory strain F62 has been shown to establish and maintain a NO steady-state level that is a function of the nitrite reductase/NO reductase ratio and is independent of cell number. The nitrite reductase activities (122-197 nmol NO2 reduced x min(-1) x OD600(-1)) and NO reductase activities (88-155 nmol NO reduced x min(-1) x OD600(-1)) in a variety of gonococcal clinical isolates were similar to the specific activities seen in F62 (241 nmol NO2 reduced x min(-1) x OD600(-1) and 88 nmol NO reduced x min(-1) x OD600(-1), respectively). In seven gonococcal strains, the NO steady-state levels established in the presence of nitrite were similar to that of F62 (801-2121 nmol x L-1 NO), while six of the strains, identified as arginine, hypoxanthine, and uracil auxotrophs (AHU), that cause asymptomatic infection in men had either two- to threefold (373-579 nmol x L-1 NO) or about 100-fold (13-24 nmol x L-1 NO) lower NO steady-state concentrations. All tested strains in the presence of a NO donor, 2,2'-(hydroxynitrosohydrazono)bis-ethanimine/NO, quickly lowered and maintained NO levels in the noninflammatory range of NO (<300 nmol x L-1). The generation of a NO steady-state concentration was directly affected by alterations in respiratory control in both F62 and an AHU strain, although differences in membrane function are suspected to be responsible for NO steady-state level differences in AHU strains.
Barth
Kenneth
K
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Box 672, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Clark
Virginia L
VL
D000693:Anaerobiosis; D001120:Arginine / Q000378:metabolism*; D052818:Autotrophic Processes; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D005260:Female; D006069:Gonorrhea / Q000382:microbiology*; D006801:Humans; D019271:Hypoxanthine / Q000378:metabolism*; D008297:Male; D009344:Neisseria gonorrhoeae / Q000201:enzymology / Q000235:genetics / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism*; D009572:Nitrite Reductases / Q000235:genetics / Q000378:metabolism; D009573:Nitrites / Q000378:metabolism*; D010088:Oxidoreductases / Q000235:genetics / Q000378:metabolism; D014498:Uracil / Q000378:metabolism*
D001426:Bacterial Proteins; D009573:Nitrites; D019271:Hypoxanthine; D009569:Nitric Oxide; D014498:Uracil; D001120:Arginine; D010088:Oxidoreductases; D009572:Nitrite Reductases; C034747:nitric-oxide reductase
Biochem J. 1969 Feb;111(4):521-35
5774477
Sex Transm Dis. 1986 Jan-Mar;13(1):29-39
3082019
Infect Immun. 1987 Jun;55(6):1359-64
3106220
Science. 1972 Oct 6;178(4056):24-30
5070513
Microbiol Mol Biol Rev. 1997 Dec;61(4):533-616
9409151
Annu Rev Microbiol. 1971;25:393-428
4949036
Am J Obstet Gynecol. 2000 Mar;182(3):644-5
10739522
Mol Microbiol. 2005 Oct;58(1):177-88
16164557
J Infect Dis. 1998 Dec;178(6):1707-12
9815223
Arch Biochem Biophys. 2004 Sep 15;429(2):237-43
15313228
Nature. 1973 Feb 2;241(5388):321-5
4633553
Infect Immun. 1984 Oct;46(1):176-81
6434425
Biochem J. 1992 Aug 15;286 ( Pt 1):111-6
1325776
J Infect Dis. 1989 Dec;160(6):1012-7
2511251
J Physiol Pharmacol. 2003 Dec;54(4):469-87
14726604
Infect Immun. 2000 Sep;68(9):5241-6
10948150
Microbiology (Reading). 1995 Mar;141 ( Pt 3):611-22
7711899
Microbiology (Reading). 1997 Feb;143 ( Pt 2):633-640
9043139
Eur J Biochem. 1994 Jan 15;219(1-2):481-90
7508388
Crit Care Med. 2000 Apr;28(4 Suppl):N37-52
10807315
J Biol Chem. 1995 Jun 9;270(23):14214-9
7775482
Science. 1977 Jun 17;196(4296):1352-3
405742
J Clin Microbiol. 1983 Jul;18(1):121-7
6411761
Mol Microbiol. 2000 Aug;37(4):839-55
10972806
BMC Biol. 2007 Sep 07;5:35
17825091
J Bacteriol. 1978 Oct;136(1):391-401
101519
Infect Immun. 1977 Oct;18(1):165-72
409684
JAMA. 1991 Nov 13;266(18):2570-3
1942402
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2676-80
9122255
Prog Neurobiol. 2000 Apr;60(6):513-30
10739087
Clin Dermatol. 2004 Nov-Dec;22(6):476-80
15596318
Br J Vener Dis. 1982 Jun;58(3):166-75
6805849
Mol Microbiol. 1994 Feb;11(4):769-75
8196548
J Mol Biol. 2002 Feb 1;315(5):1111-27
11827480
Antimicrob Agents Chemother. 1986 Apr;29(4):687-95
3085585
J Bacteriol. 1963 Jun;85:1274-9
14047217